Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery

NCT02137161 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

62

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cataract
Pseudoexfoliation Syndrome

Interventions

DRUG: Dexamethasone+Tobramycin eye drop
DRUG: Bromfenac eye drop

Sponsor

Azienda USL Reggio Emilia - IRCCS